Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New registry monitors blood vessel blocking plugs in Real-World use

NCT ID NCT04044443

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a registry that follows 108 adults who received IMPEDE or IMPEDE-FE plugs to block blood vessels in the arms or legs. The goal is to see how safe and effective these devices are in everyday medical practice. Researchers track serious side effects and whether the plugs successfully stop blood flow to the target area.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

108 people

The number who actually took part.

Started

Jul 2019

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult study participants considered candidates for a peripheral vascular embolization procedure

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Study participant is ≥18 years of age * Study participant is considered a candidate for arterial or venous embolization of the peripheral vasculature Exclusion Criteria: * Study participant has an inability to provide written informed consent * Study participant/treatment outside of the approved study device labeling, instructions for use (IFU) * Study participant is a prisoner or member of other vulnerable population

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral vascular embolization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Klinikum München rechts der Isar

    München, 81675, Germany

  • Klinikum Nürnberg

    Nuremberg, 90471, Germany

  • Klinikum StuttGart

    Stuttgart, 70174, Germany

  • St George's Hospital (St George's University Hospitals NHS Foundation Trust)

    London, United Kingdom

  • St Mary's Hospital (Imperial College Healthcare NHS Trust)

    London, United Kingdom

  • UNIVERSITÄTSKLINIKUM LEIPZIG AöR

    Leipzig, 04103, Germany

  • Uniklinikum Würzburg

    Würzburg, 97080, Germany

  • Universitätsklinikum Carl-Gustav-Carus an der Technischen Universität Dresden

    Dresden, 01307, Germany

  • Universitätsklinikum Heidelberg

    Heidelberg, 69120, Germany

  • Universitätsklinikum Schleswig-Holstein (Campus Kiel)

    Kiel, 24105, Germany